Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Yan WangDepartment of Cardiovascular Ultrasound, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.ORCID 0009-0009-9044-7204
Tingting LiuDepartment of Ultrasound, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen 518061, China.
Xiong ShenDepartment of Ultrasound, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen 518061, China.
Li XueDepartment of Cardiovascular Ultrasound, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Fei YanState Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.ORCID 0000-0003-4874-9582
Funding
Heilongjiang Provincial Natural Science Foundation PL2024H156National Key R&D Program of China 2020YFA0908800Project of Heilongjiang Provincial Health Commission 20230909020093Scientific research project of Traditional Chinese Medicine Bureau of Guangdong Province 20221090Special funded project of the Fourth Affiliated Hospital of Harbin Medical University HYDSYTB202226the Guangdong Basic and Applied Basic Research Fund Regional Joint Fund Youth Fund Project 2021A1515110145
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Early Detection of Vulnerable Plaques Using Targeted Biosynthetic Nanobubbles. · full record | OpenQuestion